Diabetes decisions — 2025

The Board remands the Veteran's claim for service connection for diabetes mellitus to obtain an adequate medical opinion addressing the possibility of a nexus between the claimed disability and his acknowledged toxic exposure risk activities.

The Board remands the claims for further development, including obtaining a medical nexus opinion and addressing outstanding records.

The Board remands the issues of entitlement to a compensable rating for hypertension, service connection for diabetes mellitus, and service connection for tinnitus due to missing evidence and potential exposure errors.

The Board denied increased ratings for coronary artery disease and diabetes mellitus, type II, but granted earlier effective dates for the service connection of these conditions.

The Board denied service connection for diabetes mellitus, major depression, high blood pressure, and a major head injury as the evidence did not support a finding that these conditions were related to the Veteran's active service.

The Board denied service connection for diabetes mellitus, blood clots, residuals of stroke, an acquired psychiatric disorder (depression), and a left shoulder disability as the weight of the evidence did not support a finding that these conditions were incurred in or are otherwise the result of active service.

The Board granted service connection for chronic pelvic pain, hysterectomy, and urinary incontinence but denied service connection for diabetic retinopathy. The appeal was dismissed for an earlier effective date of a right ankle condition.

The Board remands the claim for a new VA medical opinion to address whether the Veteran's service-connected psychiatric disability caused or aggravated obesity, which in turn led to diabetes mellitus.

The appeal was granted for readjudicating the back condition claim, but denied for diabetes mellitus and prostate cancer. The claims for diabetes and prostate cancer were remanded.

The Board denied increased ratings for the Veteran's knee and hip disabilities, granted a 20% rating for right knee semilunar cartilage condition and left knee semilunar cartilage condition, and denied service connection for hypertension and type II diabetes mellitus.

The Board denied service connection for diabetes mellitus, type II, cardiovascular disability, hypertension, thyromegaly, prostate cancer, and bladder cancer as there is no evidence of in-service exposure to herbicide agents or that the disabilities are related to such exposure.

The Board granted an effective date of March 31, 2016, for the award of TDIU based on a finding that the Veteran detrimentally relied on misleading VA communications.

The Board denied the claims for service connection for diabetes mellitus and a skin rash on the head, finding no evidence of in-service injury, event, or disease related to these conditions.

The Board remands the matter of entitlement to service connection for the cause of the Veteran's death due to a duty-to-assist error in verifying the Veteran's exposure to herbicide agents during his active-duty service.

The Board granted a rating of 60 percent for herpes and remanded the claim for service connection for diabetes mellitus type 2 as secondary to transvaginal hysterectomy status post dysmenorrhea and endometriosis.

The Board remands the claims for additional development, specifically to ensure that all relevant VA treatment records from October 2020 to December 2021 are associated with the record.

The Board denied service connection for a prostate disorder, including prostate cancer and benign prostatic hypertrophy, and dismissed the appeals for diabetes mellitus, hypertension, bilateral upper and lower extremity peripheral neuropathy, and sleep apnea due to untimeliness of the appeal.

The Board remands the claims for service connection for diabetes mellitus, prostate cancer, mucinous adenocarcinoma, heart condition, and bilateral lower extremity peripheral neuropathy to allow verification of herbicide agent exposure in Okinawa, Japan, and to obtain new VA examinations.

The Board denied service connection for skin abscess and remanded claims for asthma, diabetes mellitus, erectile dysfunction, and enuresis.

The Board denied service connection for diabetes mellitus type II as the evidence did not support a relationship between the current disability and in-service exposure or injury.